Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -16.8% | -37.8% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 0.6 | 0.6 |
Pr/Book | 1.1 |
Latest | F'cast | |
---|---|---|
Revenue | -13.7% | -3.3% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-18 | 68.35 | (6.90) | (1.27)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-19 | 73.72 | 4.29 | 0.55p | 25.5 | n/a | n/a | n/a | 0.0% |
30-Jun-20 | 78.20 | 8.07 | 1.11p | 12.6 | 0.1 | +102% | n/a | 0.0% |
30-Jun-21 | 84.33 | 3.66 | 0.45p | 55.6 | n/a | -60% | n/a | 0.0% |
30-Jun-22 | 72.77 | (12.66) | (2.14)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-23 | 70.34 | (26.56) | (3.91)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 82.10 | (17.46) | (2.56)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-25 | 106.00 | (26.80) | (2.00)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Half-Year Trading Update 2023 | 20-Jan-2023 | 07:00 | RNS |
NOTICE OF 2022 ANNUAL GENERAL MEETING | 13-Jan-2023 | 17:27 | RNS |
Suspension - Allergy Therapeutics plc | 03-Jan-2023 | 07:30 | RNS |
Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 6.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 32.25 |
52 Week Low | 5.00 |
Volume | 0 |
Shares Issued | 679.10m |
Market Cap | £42.44m |
RiskGrade | 268 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
You are here: research